论文部分内容阅读
目的:探讨妈富隆治疗青春期功能失调性子宫出血的临床疗效。方法:选取我院收治的84例青春期功能失调性子宫出血患者作为研究对象,将其随机均分为观察组和对照组,观察组服用妈富隆治疗,对照组采用口服雌孕激素和安宫黄体酮联合治疗,比较两组患者的临床疗效、出血控制时间、完全止血时间。结果:观察组治疗总有效率为97.6%,高于对照组治疗总有效率80.5%;观察组控制出血时间(26.8±1.6)h,少于对照组的(36.3±7.6)h;观察组完全止血时间(69.4±10.3)h,少于对照组的(56.8±9.6)h,差异比较有统计学意义(P<0.05)。结论:妈富隆治疗青春期功能失调性子宫出血的临床疗效显著,能够降低患者的痛苦,值得临床推广。
Objective: To investigate the clinical efficacy of Marvelon in the treatment of adolescent dysfunctional uterine bleeding. Methods: Eighty-four adolescent dysfunctional uterine bleeding patients admitted to our hospital were selected as study subjects, randomly divided into observation group and control group. The observation group was treated with Marvelon, and the control group was treated with oral estrogen and progesterone Ketone combination therapy, the clinical efficacy of two groups were compared, bleeding control time, complete bleeding time. Results: The total effective rate in observation group was 97.6%, which was higher than that in control group (80.5%). The bleeding time in observation group was (26.8 ± 1.6) h less than that in control group (36.3 ± 7.6) h. The observation group was complete The bleeding time (69.4 ± 10.3) h, less than the control group (56.8 ± 9.6) h, the difference was statistically significant (P <0.05). Conclusion: Marvelon treatment of adolescent dysfunctional uterine bleeding clinical significant effect, can reduce the suffering of patients, is worth clinical promotion.